2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).
Journal article
Konstantinides SV. et al, (2020), Eur Heart J, 41, 543 - 603
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Journal article
Knuuti J. et al, (2020), Eur Heart J, 41, 407 - 477
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Journal article
Cosentino F. et al, (2020), Eur Heart J, 41, 255 - 323
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Journal article
Mach F. et al, (2020), Eur Heart J, 41, 111 - 188
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].
Journal article
Authors/Task Force Members None. et al, (2020), Atherosclerosis, 292, 160 - 162
Ghidul societăţii europene de cardiologie (Esc)/ societăţii europene de ateroscleroză (eas) pentru diagnosticul şi tratamentul dislipidemiilor 2019: modificările lipidice în vederea reducerii riscului cardiovascular
Journal article
Mach F. et al, (2020), Revista Romana de Cardiologie, 30, 263 - 357
Maternal and perinatal Health Research Collaboration, India (MaatHRI): methodology for establishing a hospital-based research platform in a low and middle income country setting.
Journal article
Nair M. et al, (2020), F1000Res, 9
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Journal article
Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol
Investigating modifications to participant information materials to improve recruitment into a large randomized trial.
Journal article
HPS2-THRIVE Collaborative Group None. et al, (2019), Trials, 20
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.
Journal article
Authors/Task Force Members None. et al, (2019), Atherosclerosis, 290, 140 - 205
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).
Journal article
Konstantinides SV. et al, (2019), Eur Respir J, 54
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.
Journal article
Haynes R. et al, (2019), Clin Ther, 41, 1767 - 1777
Impact of ADCY9 Genotype on Response to Anacetrapib.
Journal article
Hopewell JC. et al, (2019), Circulation
Variability in aspirin efficacy: all in the genes?
Journal article
Baigent C. and Holmes MV., (2019), Eur Heart J
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
Journal article
Schlackow I. et al, (2019), Kidney Int, 96, 170 - 179
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
Journal article
Al-Shahi Salman R. et al, (2019), Lancet Neurol, 18, 643 - 652
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
Journal article
RESTART Collaboration None., (2019), Lancet, 393, 2613 - 2623
Role of aspirin in primary prevention of cardiovascular disease.
Journal article
Patrono C. and Baigent C., (2019), Nat Rev Cardiol
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Journal article
House AA. et al, (2019), Kidney Int, 95, 1304 - 1317
Chronic kidney disease, heart failure and neprilysin inhibition.
Journal article
Haynes R. et al, (2019), Nephrol Dial Transplant